MDLZ
71
-2
PCAR
45
-4
KEY
62
-3
PNW
57
-10
DIS
52
-2
HD
47
-3
DLTR
48
-3
EFX
79
-3
FSLR
63
-3
BAC
36
4
STT
48
4
BEN
36
3
MTCH
57
-5
SBUX
45
-2
ADT
25
-2
HRL
39
-2
CMA
53
-2
WAT
55
-3
WBA
22
-2
VFC
40
-5
MDLZ
71
-2
PCAR
45
-4
KEY
62
-3
PNW
57
-10
DIS
52
-2
HD
47
-3
DLTR
48
-3
EFX
79
-3
FSLR
63
-3
BAC
36
4
STT
48
4
BEN
36
3
MTCH
57
-5
SBUX
45
-2
ADT
25
-2
HRL
39
-2
CMA
53
-2
WAT
55
-3
WBA
22
-2
VFC
40
-5
Financhill
Back

Schwab Fundamental U.S. Small CompanyETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
46

FNDA
Schwab Fundamental U.S. Small CompanyETF

Last Price:
58.74
Seasonality Move:
1.01%
Buy
61

RYTM
Rhythm Pharmaceuticals

Last Price:
45.10
Seasonality Move:
4.7%
Sell
46
Schwab Fundamental U.S. Small CompanyETF (FNDA) is a Sell

Is Schwab Fundamental U.S. Small CompanyETF a Buy, Sell or Hold?

  • The current Schwab Fundamental U.S. Small CompanyETF [FNDA] share price is $57.33. The Score for FNDA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $44.23. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FNDA Stock Price Chart

What is Schwab Fundamental U.S. Small CompanyETF's stock price today?

  • The Schwab Fundamental U.S. Small CompanyETF share price today is $57.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNDA is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $44.23
    The current trend is moderately bearish and RYTM is experiencing slight selling pressure.

FNDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.83 Buy
Chaikin Money Flow: -144918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.67 - 58.95) Buy
Bollinger Bands (100): (54.18 - 57.44) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 43.39 Sell
Chaikin Money Flow: -164438 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.62 - 48.72) Sell
Bollinger Bands (100): (38.37 - 46.51) Buy

FNDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.97 Buy
20-day SMA: 56.99 Buy
50-day SMA: 56.38 Buy
200-day SMA: 54.58 Buy
8-day EMA: 57.05 Buy
20-day EMA: 56.89 Buy
50-day EMA: 56.57 Buy
200-day EMA: 54.6 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.88 Sell
20-day SMA: 45.93 Sell
50-day SMA: 45.45 Sell
200-day SMA: 41.82 Buy
8-day EMA: 45.51 Sell
20-day EMA: 45.9 Sell
50-day EMA: 45.1 Sell
200-day EMA: 40.06 Buy

Schwab Fundamental U.S. Small CompanyETF Earnings Growth & FNDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.

Schwab Fundamental U.S. Small CompanyETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):